Best Biotech Etf To Buy Now Page

Strategy: Market-cap weighted, dominated by giants like Vertex, Gilead, and Amgen . Expense Ratio: 0.44% . Best for: Low-cost core exposure .

Strategy: Uses a modified equal-weight index, giving smaller companies more influence . Expense Ratio: 0.35% . Best for: Conservative "buy the basket" exposure . best biotech etf to buy now

Your (e.g., comfortable with high volatility)? Your investment timeframe ? Strategy: Market-cap weighted

Strategy: Actively managed by Cathie Wood's team, targeting "disruptive" innovation . Expense Ratio: 0.75% . Comparison of Key Metrics 1-Year Return Expense Ratio Small/Mid-Cap Equal Weight IBB Large-Cap Market Weighted SBIO Clinical Trial Breakthroughs IBBQ Nasdaq Biotech Index Data based on recent 2026 market reports . dominated by giants like Vertex

Strategy: Tracks the Nasdaq Biotechnology Index at a significantly lower price point . Expense Ratio: 0.19% .